Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy

Documenti analoghi

• The cancer antigenome
  di: Heemskerk, Bianca, et al.
  Pubblicazione: (2013)
• TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients
  di: Kvistborg, Pia, et al.
  Pubblicazione: (2012)
• Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
  di: van Rooij, Nienke, et al.
  Pubblicazione: (2013)
• Acquired and intrinsic resistance in cancer immunotherapy
  di: Kelderman, Sander, et al.
  Pubblicazione: (2014)
• Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up
  di: van den Berg, Joost H, et al.
  Pubblicazione: (2020)